Skip to main content

Celgene Corporation



) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 0.3%. By the end of trading, Celgene Corporation fell 57 cents (-0.8%) to $69.08 on average volume. Throughout the day, 2.5 million shares of Celgene Corporation exchanged hands as compared to its average daily volume of three million shares. The stock ranged in price between $68.40-$69.38 after having opened the day at $69.21 as compared to the previous trading day's close of $69.65. Other company's within the Health Care sector that declined today were:

Dynatronics Corporation



), down 16.7%,

Aoxing Pharmaceutical Company



), down 13.2%,

American Caresource Holdings



), down 9.1%, and

Scroll to Continue

TheStreet Recommends

Galena Biopharma



), down 8.7%.

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes various therapies to treat cancer and immune-inflammatory related diseases primarily in the United States and Europe. Celgene Corporation has a market cap of $30.58 billion and is part of the


industry. The company has a P/E ratio of 21.6, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 2.7% year to date as of the close of trading on Tuesday. Currently there are 22 analysts that rate Celgene Corporation a buy, no analysts rate it a sell, and six rate it a hold.

TheStreet Ratings rates Celgene Corporation as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the positive front,

Rosetta Genomics



), up 51.3%,




), up 24%,

Accelr8 Technology Corporation



), up 17.3%, and




), up 17.2%, were all gainers within the health care sector with

Edwards Life



) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care